It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
SOFA exempts U.S. forces from Japan’s laws, as it does its COVID safety measures

Commentary / Japan Jan 12, 2022

SOFA exempts U.S. forces from Japan’s laws, as it does its COVID safety measures

by Edo Naito

Beyond the issues associated with the U.S. military’s lax COVID-19 containment measures, SOFA has a long history of incidents.

Biogen stung as U.S. limits coverage of Alzheimer’s therapy

World / Science & Health Jan 12, 2022

Biogen stung as U.S. limits coverage of Alzheimer’s therapy

by John Tozzi, Angelica Peebles and Robert Langreth

Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.

Pfizer starts making vaccine that targets both omicron and the original COVID virus

World / Science & Health Jan 11, 2022

Pfizer starts making vaccine that targets both omicron and the original COVID virus

by Riley Griffin

While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.

Unvaccinated creating another kind of COVID-19 victim

Commentary / World Jan 10, 2022

Unvaccinated creating another kind of COVID-19 victim

by Peter Singer

People who make choices that are likely to harm others, such as refusing vaccinations, and have been warned of the consequences of those choices must take responsibility for them.

Hair-loss treatment for votes? South Korea's hairy debate

Asia Pacific / Politics Jan 6, 2022

Hair-loss treatment for votes? South Korea's hairy debate

The Democratic Party presidential candidate has divided opinion with his proposal to allow public health care insurance to cover hair-loss treatment.

Climate change is also a very real public health emergency

Commentary / World Jan 2, 2022

Climate change is also a very real public health emergency

by Cesar Chelala

The impact of global warming has been considerable on people of all ages, particularly the most vulnerable and those with underlying health conditions.

Tokyo researchers work toward 'dream' COVID-19 vaccine that gives protection for life

National / Science & Health Dec 29, 2021

Tokyo researchers work toward 'dream' COVID-19 vaccine that gives protection for life

by Osamu Tsukimori

By repurposing the vector used in the long-proven smallpox vaccine, Michinori Kohara hopes to offer more enduring COVID-19 protection against variants that have yet to develop.

Tardy COVID-19 vaccine makers under fire for trials in developing nations

Business Dec 27, 2021

Tardy COVID-19 vaccine makers under fire for trials in developing nations

by Kanoko Matsuyama

Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.

Japan government panel approves first oral COVID-19 pill

National / Science & Health Dec 24, 2021

Japan government panel approves first oral COVID-19 pill

Clinical trial data shows that patients given the pill within five days of developing symptoms were 30% less likely to be hospitalized or die.

Japan university finds Alzheimer's drug effective in treating ALS

National / Science & Health Dec 24, 2021

Japan university finds Alzheimer's drug effective in treating ALS

There are drugs that can slow the progress of the disease, but the new medicine could be the first to work on protein accumulated in the brain and spinal cord.

Biden can promise action, but omicron is in charge right now

Commentary / World Dec 22, 2021

Biden can promise action, but omicron is in charge right now

by Jonathan Bernstein

The U.S. president's biggest policy promise during the 2020 campaign was perhaps his vow to attack COVID-19 in a professional and competent way.

Ivermectin for COVID? Unproven treatment stokes concern in Japan

National | FOCUS Dec 21, 2021

Ivermectin for COVID? Unproven treatment stokes concern in Japan

by Osamu Tsukimori

Although the treatment has received some support from Japan's medical establishment and studies are ongoing, ivermectin is not approved as a COVID-19 remedy in the country.

« 1 … 19 20 21 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times